Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2026-02-12 @ 12:33 AM
Study NCT ID:
NCT03805594
Status:
COMPLETED
Last Update Posted:
2025-02-25
First Post:
2019-01-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor:
University of California, San Francisco
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Castration Levels of Testosterone | View |
| None | Castration-Resistant Prostate Carcinoma | View |
| None | Metastatic Prostate Carcinoma | View |
| None | Prostate Adenocarcinoma | View |
| None | Stage IV Prostate Cancer | View |
| None | Stage IVA Prostate Cancer | View |
| None | Stage IVB Prostate Cancer | View |
Keywords: